Technique for the Laparoscopic Removal of Essure Microinserts

Department

OB/GYN

Document Type

Article

Publication Title

Journal of Minimally Invasive Gynecology

Abstract

STUDY OBJECTIVE: To describe our technique for the laparoscopic removal of Essure microinserts (Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ). DESIGN: Step-by-step explanation of the procedure using video (Canadian Task Force classification III). SETTING: Hysteroscopic sterilization using tubal microinsert devices has generally been reported to be well tolerated in terms of procedure-related pain. Persistent pelvic pain requiring microinsert removal has been described in a few case reports and series and was estimated at 0.16% of cases (7 cases [49/4,274]) in a large retrospective study. Removal is usually performed at the patient's request and/or because of persistent pelvic pain unresponsive to other treatments with no other etiologies found. In general, the pain starts at the initial insertion and persists thereafter. Both laparoscopic and hysteroscopic removal approaches have been described in the few cases reported. INTERVENTIONS: In this video, we describe our technique for the surgical management of pelvic pain resulting from Essure microinserts. We performed laparoscopic removal of bilateral Essure microinserts in a 30-year-old G3P3 (Gravida 3 Para 3) with bilateral Essure devices placed 2 years before the procedure; hysterosalpingogram confirmed appropriate placement. The patient was suffering from bilateral sharp pelvic pain since insertion that was related to positional change and movements but unrelated to periods along with menorrhagia. A pelvic ultrasound showed a small intramural uterine leiomyoma. She failed a trial of treatment of her symptoms with a levonorgestrel intrauterine device. The patient requested removal of her Essure microinserts and endometrial ablation. She underwent laparoscopic bilateral Essure microinsert removal and bilateral salpingectomy along with hysteroscopic removal of the levonorgestrel intrauterine device and endometrial ablation. Her surgery was uneventful, and she was discharged the day of the surgery. Her symptoms resolved completely after the procedure. CONCLUSION: Laparoscopic removal of Essure microinserts in the context of persistent pelvic pain after insertion is a feasible and effective procedure and allows the avoidance of performing a hysterectomy when the patient declines this procedure. Sound knowledge of the Essure components and meticulous surgical technique are paramount for successful results.

First Page

472

DOI

10.1016/j.jmig.2016.01.005

Volume

23

Issue

4

Publication Date

5-1-2016

Medical Subject Headings

Adult; Device Removal (methods); Endometrial Ablation Techniques (adverse effects); Female; Humans; Hysterectomy (methods); Hysterosalpingography (methods); Hysteroscopy (adverse effects); Intrauterine Devices; Laparoscopy (methods); Parity; Pelvic Pain (etiology, surgery); Pelvis; Retrospective Studies; Salpingectomy (methods); Sterilization, Tubal (adverse effects, instrumentation, methods); Ultrasonography

PubMed ID

26776673

Link to Full Text

Share

COinS